An Eczema Drug Takes Spot TV’s Top Spot


There’s little change in activity shown in the latest Media Monitors Spot Ten TV report. However, the big new No. 1 is noteworthy, as it reflects a big investment in broadcast by Sanofi US for a treatment for skin disorders.

Please Login to view this premium content. (Not a member? Join Today!)